BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35117639)

  • 1. Relationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1α, prognosis and
    Shen LF; Zhou SH; Yu Q
    Transl Cancer Res; 2020 Apr; 9(4):2824-2837. PubMed ID: 35117639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
    Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
    Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorodeoxyglucose uptake in laryngeal carcinoma is associated with the expression of glucose transporter-1 and hypoxia-inducible-factor-1α and the phosphoinositide 3-kinase/protein kinase B pathway.
    Zhao K; Yang SY; Zhou SH; Dong MJ; Bao YY; Yao HT
    Oncol Lett; 2014 Apr; 7(4):984-990. PubMed ID: 24944654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors.
    Xu H; Li B; Yu W; Wang H; Zhao X; Yao Y; Huang D
    Nucl Med Commun; 2013 Oct; 34(10):953-8. PubMed ID: 23887273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
    Yamada T; Uchida M; Kwang-Lee K; Kitamura N; Yoshimura T; Sasabe E; Yamamoto T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):464-71. PubMed ID: 22676927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG imaging of human atherosclerotic carotid plaques reflects gene expression of the key hypoxia marker HIF-1α.
    Pedersen SF; Græbe M; Hag AM; Højgaard L; Sillesen H; Kjær A
    Am J Nucl Med Mol Imaging; 2013; 3(5):384-92. PubMed ID: 24116346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor 1α on the uptake of fluorodeoxyglucose ((18)f) in the human pancreatic cancer cell line, patu8988.
    Fan G; Bo J; Wan R; Peng M; Luan Y; Deng M; Xu L
    Cancer Biother Radiopharm; 2015 May; 30(4):160-8. PubMed ID: 25853522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma].
    XU O; LI XM; WANG MX; QU YT; LU XY; SHAN CG; SUN QJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):330-3. PubMed ID: 22800355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.
    Kasahara N; Kaira K; Bao P; Higuchi T; Arisaka Y; Erkhem-Ochir B; Sunaga N; Ohtaki Y; Yajima T; Kosaka T; Oyama T; Yokobori T; Asao T; Nishiyama M; Tsushima Y; Kuwano H; Shimizu K; Mogi A
    Lung Cancer; 2018 May; 119():71-77. PubMed ID: 29656756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma.
    Wu XH; Chen SP; Mao JY; Ji XX; Yao HT; Zhou SH
    Oncol Lett; 2013 Jan; 5(1):261-266. PubMed ID: 23255932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation of prognostic biomarkers (Ki-67, Bcl-2, HIF-1α, cyclin D1) with metabolic tumor volume measured by F-FDG PET/CT inlaryngeal cancer.
    Eryilmaz A; Cengiz A; Basal Y; Meteoglu I; Omurlu IK; Yurekli Y
    J Cancer Res Ther; 2018; 14(5):994-998. PubMed ID: 30197337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
    Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck.
    Kunder S; Chatterjee A; Manna S; Mahimkar M; Patil A; Rangarajan V; Budrukkar A; Ghosh-Laskar S; Agarwal JP; Gupta T
    World J Nucl Med; 2021; 20(3):228-236. PubMed ID: 34703390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
    Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
    J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of HIF-1α/HIF-2α expression with FDG uptake in lung adenocarcinoma.
    Higashi K; Yamagishi T; Ueda Y; Ishigaki Y; Shimasaki M; Nakamura Y; Oguchi M; Takegami T; Sagawa M; Tonami H
    Ann Nucl Med; 2016 Dec; 30(10):708-715. PubMed ID: 27663442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor immunity is related to
    Imai H; Kaira K; Hashimoto K; Nitanda H; Taguchi R; Yanagihara A; Umesaki T; Yamaguchi O; Mouri A; Kawasaki T; Yasuda M; Kobayashi K; Sakaguchi H; Kuji I; Kagamu H
    Cancer Med; 2021 Sep; 10(18):6317-6326. PubMed ID: 34363337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
    Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A
    Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.
    Kasahara N; Kaira K; Yamaguchi K; Masubuchi H; Tsurumaki H; Hara K; Koga Y; Sakurai R; Higuchi T; Handa T; Oyama T; Yokobori T; Shimizu K; Asao T; Hisada T
    Lung Cancer; 2019 Aug; 134():180-186. PubMed ID: 31319979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
    Furukawa T; Miyata Y; Kushitani K; Mimae T; Tsutani Y; Takeshima Y; Okada M
    Jpn J Clin Oncol; 2015 Dec; 45(12):1154-61. PubMed ID: 26386467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.